Clinical-stage biotech making dissolvable microarray drug and vaccine patches.
| Date | Round | Amount |
|---|---|---|
| May 2023 | Series A US biotech Micron Biomedical raised an additional $3M from J2 Ventures, taking its Series A to $17M. | $3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.